Asian Spectator

The Times Real Estate

.

Breakthrough Innovation in Cancer Care From Merck Pipeline to ...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
DARMSTADT, Germany, May 14, 2020 /PRNewswire-AsiaNet/ -- - Results from two studies of BAVENCIO® to be featured in ASCO press briefing- Primary efficacy, biomarker and HRQoL analyses for tepotinib†, the first MET inhibitor to have received a regulatory approval for NSCLC with MET gene alterations ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Expert Legal Help | Personal Injury Lawyer in Brisbane

Suffering a personal injury can be a traumatic and life-changing experience, leaving you wondering what to do next. Navigating the complex world of personal injury law in Brisbane can be overwhelmin...

#IndonesiaGelap: Alarm bagi publik agar tak terlena narasi penguasa

Mahasiswa dari berbagai kampus berpartisipasi dalam aksi Indonesia Gelap di Jakarta untuk memprotes kebijakan pemerintah.@jackjackparrrBermula dari media sosial, tagar #IndonesiaGelap menjadi bentuk a...

Ketika pemberitaan penuh tekanan, bagaimana cara tetap ‘update’ tanpa ‘doomscrolling’?

Mart Production/PexelsAwalnya sesederhana kita mengintip media sosial favorit di tengah malam sebelum tidur. Lalu muncullah judul-judul berita yang menarik perhatian dengan keterangan “breaking ...